Vaccine safety and approvals should not be a matter of concern

India is now in the midst of rolling two Covid-19 vaccines across the entire country. But, over the last few weeks, there have been several occasions where members of the medical community have indicated that they would like to wait for a particular brand of a vaccine rather than use the DCGI approved the Covishield and Covaxin which received approval on 3rd January and which took into consideration risk-benefit analysis of vaccine usage among the Indian population.
Read more...

;